Big Moving Stock keep track of the biggest moving stocks in the market.


Nasdaq: GOOG BIIB NFLX IBB AMZN TSLA ILMN ALXN AMGN CHTR WYNN COST GMCR SIAL VRTX SLXP CELG WDC SBAC
Nyse: ACT V LNKD PPG AGN MCK IVV GS LMT SPG FDX MMM IBM PXD NOC TWC APD HUM CMI GD
New Highs: BIIB IBB SHW LNKD EQIX PPG LMT WHR SPG BWLD PRGO AVB MMM NOC APD HUM BXP FFIV ENR LLL

The Hot Industries

Specialty Chemicals 2
Aerospace/Defense Products & Services 2
Chemicals - Major Diversified 1

The Hot Sectors

Industrial Goods 4
Financial 3
Basic Materials 3

CELG Stock Chart


CELG
Analyze

Sector:

Healthcare
Daily

Industry:

Biotechnology
Weekly

Employees:

5,100
Monthly

Website:

http://www.celgene.com

CELG Celgene Corporation

Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies to treat cancer and immune-inflammatory related diseases in the United States and internationally. The company’s commercial stage products include REVLIMID, an oral immunomodulatory drug for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), and mantle cell lymphoma; VIDAZA, a pyrimidine nucleoside analog to treat intermediate-2 and high-risk MDS, and chronic myelomonocytic leukemia, as well as acute myeloid leukemia (AML); ABRAXANE, a solvent-free chemotherapy product for the treatment of breast, non-small cell lung, pancreatic, and gastric cancers; and POMALYST/IMNOVID for the treatment of multiple myeloma. Its commercial stage products also comprise THALOMID for the patients with multiple myeloma and for the acute treatment of the cutaneous manifestations of erythema nodosum leprosum; ISTODAX to treat cutaneous T-cell lymphoma; and FOCALIN, FOCALIN XR, and RITALIN LA products. The company’s pre clinical and clinical stage products consist of OTEZLA for the treatment of psoriatic arthritis, psoriasis, and ankylosing spondylitis; CC-122 and CC-220 to treat hematological and solid tumor cancers; cellular therapies, such as PDA-001 and PDA-002 for Crohn’s and peripheral arterial diseases; CC-486, to treat MDS, AML, and solid tumors; Sotatercept and ACE-536 for the treatment of anemia in patients with rare blood disorders; CC-223 and CC-115 for lymphomas, hepatocellular, and prostate cancers; and CC-292 for the treatment of chronic lymphocytic leukemia and lymphomas. It has strategic drug discovery collaboration with Abide Therapeutics to enhance the treatment paradigm for patients with immune disorders. Celgene Corporation was founded in 1980 and is headquartered in Summit, New Jersey.

favicon

'Mad Money' Lightning Round: GE Is a Good Stock With Good Yield

18 Dec 2014, 5:10 amSearch Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener. NEW YORK (TheStreet) -- Here's what Jim Cramer had to say about some of the stocks callers offered up during the Mad Money Lightning Round Wednesday evening: Sanofi : "I'm more skittish on this one. I'd go with AbbVie or Bristol-Myers Squibb ." 3D Systems : "The 3-D market is saturated. I like ...
favicon

Lightning Round: Good stock with a good yield

17 Dec 2014, 4:57 pmAre you ready skeedaddy???!!! It's time for the Lightning Round. Cramer makes the call on viewer favorites.
favicon

Biotech Stock Roundup: Sophiris & Cyclacel Plunge on Data, ChemoCentryx Gains on Positive Results - Analyst Blog

17 Dec 2014, 8:26 amIt has been a relatively quiet week with the holiday season coming up though a few companies came out with important pipeline updates.
favicon

Scanning Biotech Equities -- Celgene, Novavax, Amarin, Immunomedics, and Aeterna Zentaris

17 Dec 2014, 6:56 amLONDON, December 17, 2014 /PRNewswire/ -- Investor-Edge has initiated coverage on the following equities: Celgene Corporation (NASDAQ: CELG), Novavax Inc. (NASDAQ: NVAX), Amarin Corporation PLC (NASDAQ: AMRN), Immunomedics Inc. (NASDAQ: IMMU), and Aeterna Zentaris Inc. (NASDAQ: AEZS)....
favicon

S&P 500 Analyst Moves: CELG

11 Dec 2014, 10:12 amThe latest tally of analyst opinions from the major brokerage houses shows that among the components of the S&P 500 index, Celgene Corp. (CELG) is now the #14 analyst pick, moving up by 1 spot.         This rank is formed by averaging the analyst opinions for each component from each broker, and then ranking the 500 components by those average opinion values.
favicon

Don't Mix Other Trading Systems When You Invest CAN SLIM Style

10 Dec 2014, 4:09 pmA little bit of this and a little bit of that is fine when you're putting together a spice mix to put on your roast or when you're adding toppings on your frozen yogurt. When trading stocks, you shouldn't ...
favicon

Jim Cramer's Five Best Stock Picks for the Biotech Sector

2 Dec 2014, 12:17 pmTheStreet's Jim Cramer has selected 12 sectors where he thinks investors should put their money. Biotech stocks have had a "monstrous" year. Here are Cramer's best picks. Click to view a price quote on CELG . Click to research the Drugs industry.
favicon

Critical Alerts For Noodles & Company, Goldcorp, YY, Celgene and LinkedIn Released By InvestorsObserver

2 Dec 2014, 7:43 amCHICAGO, Dec. 2, 2014 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for NDLS, GG, YY, CELG and LNKD. To see what our analysts have discovered about a particular stock, read the InvestorsObserver's PriceWatch Alert by selecting the corresponding link. (Note: You...
favicon

Celgene recommends shareholders ignore mini-tender

1 Dec 2014, 3:04 pmCelgene (NASDAQ: CELG ) urges shareholders to ignore TRC Capital's unsolicited mini-tender offer to buy 1M shares of CELG common stock at $101.75, a discount of over 10% from today's close of $113.43.
favicon

Stock of the Week: Celgene Corp. (CELG)

24 Nov 2014, 6:42 amStock of the Week: Celgene Corp. (CELG)